Home › Ovarian Epithelial Carcinoma › Florida
Ovarian Epithelial Carcinoma clinical trials in Florida
11 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Florida.
Cities in Florida
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Advent Health, Orlando
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT06915025Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer
- Research Site, Tamarac
- Research Site, Tampa
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT07851025Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Broward Health Medical Center, Fort Lauderdale
- Jupiter Medical Center, Jupiter
- Mount Sinai Medical Center, Miami Beach
- and 2 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 28, 2026 · NCT06819007A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Jupiter Medical Center /ID# 276616, Jupiter
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 20, 2026 · NCT06890338Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
- Research Site, Miami
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07816666Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT04429542Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, Fort Lauderdale
- Research Site, Gainesville
- Research Site, Jupiter
- and 2 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Jacksonville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Mayo Clinic Florida, Jacksonville
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.